$BMI

Stifel cuts Badger Meter stock price target on margin concerns

Stifel reduced its price target for Badger Meter (NYSE:BMI) to $150 from $165, citing margin concerns, while maintaining a Buy rating. The stock is down 27% year-to-date. The firm expects updates on project ramp-ups and large projects to be key for investor confidence. Badger Meter reports earnings on October 22, with Q2 revenue at $222.3M, slightly above estimates, and EPS at $1.02, in line with expectations.

Original reporting
Published Oct 19, 2026, 12:50 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 19, 2026, 1:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$BMI
Bearish
high confidence
Mentioned
$BMI
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$BMIBearishMed
01

Why it matters

Analyst target reduction may trigger short‑term selling pressure ahead of the upcoming earnings release.

02

Market read

The downgrade adds fresh negative sentiment to BMI, a small‑cap industrial stock, ahead of its earnings.

03

What to watch

Potential upside from the PRASA project shipment and a 33‑year dividend streak could support the stock.

Relevance 6/10Novelty 6/10Timing: before earnings on Oct 22

Background

Stifel's revision reflects concerns over inflationary pressure and mix impacts on Badger Meter's margins in H2 2026.

Company-level read

Ticker impact

$BMIBearishHigh confidence
Context

Stifel lowered its price target on Badger Meter to $150 from $165, citing margin concerns and weaker second‑half outlook.

Expected impact

likely pressure as investors price in margin concerns and a lower target

Evidence & confidence

The target cut is a fresh analyst action and the stock is trading well below the new target, suggesting downside risk before the Oct 22 earnings release.

Market effects

Margin pressure highlights challenges for water‑meter manufacturers and could affect peers in the industrial instrumentation sector.

Limited to U.S. industrial stocks; no broader market effect.

Low global relevance.

Counterpoint

If the company can improve project ramp‑ups and margin mix, the target cut may be overly pessimistic.

Key entities

  • Badger Meter

    U.S. water‑meter manufacturer (NYSE:BMI).

  • Stifel

    Equity research firm providing the price‑target revision.

Related articles

$BMIMed

Badger Meter 3Q 2026: Revenue $235.9M, Net income $35.9M, EPS $1.24— 10-Q Summary

Badger Meter reported Q3 2026 revenue of $235.9M, up 0.1% YoY, with net income rising 2.4% to $35.9M and EPS increasing 4.2% to $1.24. SaaS growth and ultrasonic meter volumes drove margin improvements, while nine-month sales fell 5.1% due to utility project timing. The company acquired UDlive in May 2026, contributing $7.7M in revenue. Electronic-component shortages and tariffs pose risks.

$BMIMedAI 8/10

Badger Meter Inc (BMI) (Q3 2026) Earnings Call Highlights: Margin Expansion and Dividend

Badger Meter (BMI) reported Q3 2026 earnings, expecting low single-digit year-over-year revenue growth in Q4 and a low single-digit full-year organic revenue decline. The company attributed strong gross margins to ultrasonic meter and software growth, with confidence in maintaining margins within the 39%-42% range. CEO Kenneth Bockhorst highlighted sequential improvement in day-to-day replacement business and strong long-term outlook for projects like PRASA AMI.

$BMIMed

Key facts: Badger Meter (BMI) Q3 EPS +4%, $55M buyback; OneNetwork

Badger Meter (BMI) reported Q3 2026 sales of $235.9M, EPS of $1.24 (+4%), and net income of $35.9M. Operating income was $47.7M with margins of 20.2% and 41.9%. The company announced a $55M buyback and a 10% dividend increase. It also launched OneNetwork, a real-time platform, and began shipping equipment for the PRASA project, with installations expected in Q4 2026.